Leaders Pledge To Push For Full Funding Of ACT-Accelerator At Inaugural Meeting

U.N. News: Leaders pledge ‘quantum leap’ towards fully funding COVID-19 vaccines and treatments
“Global leaders, including more than 30 heads of state and ministers, have underlined their commitment towards fast-tracking the development and production of COVID-19 tests, medicines, and vaccines that will be available for anyone, anywhere, who needs them. Following a virtual meeting on Thursday, they pledged to advocate for the $35 billion still required for the Access to COVID-19 Tools (ACT) Accelerator, to realize the goal of producing two billion vaccine doses, 245 million treatments, and 500 million tests. … The ACT-Accelerator was launched in April and so far has received $2.7 billion, or less than one-tenth of the necessary financing. The virtual gathering held on Thursday marked the inaugural meeting of its Facilitation Council. … The U.N. agency reported that more than 170 countries are now engaged in a COVID-19 Vaccine Facility [COVAX], one of four pillars under the accelerator. Ten vaccine candidates are currently being evaluated, nine of which are in clinical trials…” (9/10).

Additional coverage of the meeting and the ACT-Accelerator is available from CIDRAP News, Reuters, and VOA News.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.